All
Cancer & the skin Managing the cutaneous side effects of cancertreatments
May 1st 2006National report - Chemotherapy and radiation can createunwanted results ranging from hair loss to pigment problems.However, an expert tells Dermatology Times that with some newbiologically targeted cancer therapies, skin-related side effectsseem to provide a barometer of these treatments' effectiveness.
More than lip service: Lower face options minimize downtime
May 1st 2006National report - For treating the lips and lower face,experts tell Dermatology Times that options including fillers,botulinum toxin injections and newer resurfacing technologies candeliver excellent cosmetic results usually with little or nodowntime.
Soft-tissue augmentation need not be a bruising experience
May 1st 2006National report - While soft-tissue fillers offer the uniquebenefit of providing fast correction for busy patients who don'twant to have the down-time for a face-lift, bruising can throw amonkey wrench into the best-laid plans for stellar patientsatisfaction.
Microbicides take center stage among prospects for HIV prevention
May 1st 2006London - Intravaginal microbicides currently represent themost promising strategy for allowing women to protect themselvesagainst HIV transmission, according to Jonathan F. Weber, M.D., whospoke at the Annual Meeting of the European Academy of Dermatologyand Venereology.
Study questions relevance of antibiotic resistance
May 1st 2006Not only was there little to no correlation between drug resistanceand clinical response, but the rates of good responses were higherin the resistant patients than in those with non-resistant P. acnesfor four of the five antibiotics (75 percent to 100 percent vs. 65percent to 85 percent).
ALA-PDT most effective with bluelight, study shows
May 1st 2006San Francisco - Interim results of a phase 2,vehicle-controlled, bilateral study evaluating the efficacy andsafety of broad area topical 5-aminolevulenic acid (ALA, LevulanKerastick, DUSA Pharmaceuticals) photodynamic therapy (PDT) withvarious light sources show that ALA plus blue light (BLU-U, DUSAPharmaceuticals) was significantly more effective than vehicle plusblue light in improving facial photodamage, but the statisticalanalyses did not find ALA pretreatment enhanced the benefitsachieved using an intense pulsed light source (IPL; Quantum,Lumenis) or a pulsed dye laser (PDL; VStar, Cynosure), said RobertA. Weiss, M.D., associate professor of dermatology, Johns HopkinsUniversity School of Medicine, Baltimore, and an investigator inthe phase 2 trial.
Assessing conflicts of interest
May 1st 2006San Francisco - Faced with a jungle of potential conflicts ofinterest in their various roles as providers, educators, students,advisers, committee members and investigators, physicians mightconsider their answers to a few pragmatic questions in judging theethics of their conduct, according to David M. Pariser, M.D.,speaking at the 64th Annual Meeting of the American Academy ofDermatology (AAD), here.
Study suggests extra botulinum toxin A injections may be unnecessary in treating glabellar wrinkles
April 6th 2006Berlin -- According to a study reported in the March issue of the Archives of Dermatology, while three central injection sites are essential for the treatment of glabellar wrinkles with botulinum toxin A, the use of two additional injection sites targeting the frontalis muscle did not improve efficacy.